Global Tigecycline Market Growth 2023-2030
- Category: Healthcare
- Published Date: May 2023
- Publisher: LP Information
- Pages: 102
As the global economy mends, the 2022 growth of Tigecycline will have significant change from previous year. According to our (Intelligence Market Report) latest study, the global Tigecycline market size is USD million in 2022 from USD 1413.9 million in 2022, with a change of % between 2022 and 2022. The global Tigecycline market size will reach USD 4658 million in 2030, growing at a CAGR of 18.6% over the analysis period.
The United States Tigecycline market is expected at value of US$ million in 2022 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tigecycline market, reaching US$ million by the year 2030. As for the Europe Tigecycline landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tigecycline players cover Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, and Jiangsu Hansoh Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tigecycline market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2019-2022, in Section 2.3; and forecast to 2030 in section 12.6
Original Drug
Generic Drug
Segmentation by application: breakdown data from 2019-2022, in Section 2.4; and forecast to 2030 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
The United States Tigecycline market is expected at value of US$ million in 2022 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tigecycline market, reaching US$ million by the year 2030. As for the Europe Tigecycline landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tigecycline players cover Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, and Jiangsu Hansoh Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tigecycline market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2019-2022, in Section 2.3; and forecast to 2030 in section 12.6
Original Drug
Generic Drug
Segmentation by application: breakdown data from 2019-2022, in Section 2.4; and forecast to 2030 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tigecycline Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tigecycline by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tigecycline by Country/Region, 2019, 2023 & 2030
2.2 Tigecycline Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Tigecycline Sales by Type
2.3.1 Global Tigecycline Sales Market Share by Type (2019-2022)
2.3.2 Global Tigecycline Revenue and Market Share by Type (2019-2022)
2.3.3 Global Tigecycline Sale Price by Type (2019-2022)
2.4 Tigecycline Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.5 Tigecycline Sales by Application
2.5.1 Global Tigecycline Sale Market Share by Application (2019-2022)
2.5.2 Global Tigecycline Revenue and Market Share by Application (2019-2022)
2.5.3 Global Tigecycline Sale Price by Application (2019-2022)
3 Global Tigecycline by Company
3.1 Global Tigecycline Breakdown Data by Company
3.1.1 Global Tigecycline Annual Sales by Company (2020-2022)
3.1.2 Global Tigecycline Sales Market Share by Company (2020-2022)
3.2 Global Tigecycline Annual Revenue by Company (2020-2022)
3.2.1 Global Tigecycline Revenue by Company (2020-2022)
3.2.2 Global Tigecycline Revenue Market Share by Company (2020-2022)
3.3 Global Tigecycline Sale Price by Company
3.4 Key Manufacturers Tigecycline Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tigecycline Product Location Distribution
3.4.2 Players Tigecycline Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tigecycline by Geographic Region
4.1 World Historic Tigecycline Market Size by Geographic Region (2019-2022)
4.1.1 Global Tigecycline Annual Sales by Geographic Region (2019-2022)
4.1.2 Global Tigecycline Annual Revenue by Geographic Region
4.2 World Historic Tigecycline Market Size by Country/Region (2019-2022)
4.2.1 Global Tigecycline Annual Sales by Country/Region (2019-2022)
4.2.2 Global Tigecycline Annual Revenue by Country/Region
4.3 Americas Tigecycline Sales Growth
4.4 APAC Tigecycline Sales Growth
4.5 Europe Tigecycline Sales Growth
4.6 Middle East & Africa Tigecycline Sales Growth
5 Americas
5.1 Americas Tigecycline Sales by Country
5.1.1 Americas Tigecycline Sales by Country (2019-2022)
5.1.2 Americas Tigecycline Revenue by Country (2019-2022)
5.2 Americas Tigecycline Sales by Type
5.3 Americas Tigecycline Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tigecycline Sales by Region
6.1.1 APAC Tigecycline Sales by Region (2019-2022)
6.1.2 APAC Tigecycline Revenue by Region (2019-2022)
6.2 APAC Tigecycline Sales by Type
6.3 APAC Tigecycline Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tigecycline by Country
7.1.1 Europe Tigecycline Sales by Country (2019-2022)
7.1.2 Europe Tigecycline Revenue by Country (2019-2022)
7.2 Europe Tigecycline Sales by Type
7.3 Europe Tigecycline Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tigecycline by Country
8.1.1 Middle East & Africa Tigecycline Sales by Country (2019-2022)
8.1.2 Middle East & Africa Tigecycline Revenue by Country (2019-2022)
8.2 Middle East & Africa Tigecycline Sales by Type
8.3 Middle East & Africa Tigecycline Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tigecycline
10.3 Manufacturing Process Analysis of Tigecycline
10.4 Industry Chain Structure of Tigecycline
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tigecycline Distributors
11.3 Tigecycline Customer
12 World Forecast Review for Tigecycline by Geographic Region
12.1 Global Tigecycline Market Size Forecast by Region
12.1.1 Global Tigecycline Forecast by Region (2023-2030)
12.1.2 Global Tigecycline Annual Revenue Forecast by Region (2023-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tigecycline Forecast by Type
12.7 Global Tigecycline Forecast by Application
13 Key Players Analysis
13.1 Pfizer (Wyeth)
13.1.1 Pfizer (Wyeth) Company Information
13.1.2 Pfizer (Wyeth) Tigecycline Product Offered
13.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer (Wyeth) Main Business Overview
13.1.5 Pfizer (Wyeth) Latest Developments
13.2 Sino Biopharmaceutical
13.2.1 Sino Biopharmaceutical Company Information
13.2.2 Sino Biopharmaceutical Tigecycline Product Offered
13.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sino Biopharmaceutical Main Business Overview
13.2.5 Sino Biopharmaceutical Latest Developments
13.3 Zhejiang Hisun Pharma
13.3.1 Zhejiang Hisun Pharma Company Information
13.3.2 Zhejiang Hisun Pharma Tigecycline Product Offered
13.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zhejiang Hisun Pharma Main Business Overview
13.3.5 Zhejiang Hisun Pharma Latest Developments
13.4 Jiangsu Hansoh Pharmaceutical
13.4.1 Jiangsu Hansoh Pharmaceutical Company Information
13.4.2 Jiangsu Hansoh Pharmaceutical Tigecycline Product Offered
13.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.4.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Tigecycline Product Offered
13.5.3 Abbott Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Natco Pharma
13.6.1 Natco Pharma Company Information
13.6.2 Natco Pharma Tigecycline Product Offered
13.6.3 Natco Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Natco Pharma Main Business Overview
13.6.5 Natco Pharma Latest Developments
13.7 Lyka Labs Limited
13.7.1 Lyka Labs Limited Company Information
13.7.2 Lyka Labs Limited Tigecycline Product Offered
13.7.3 Lyka Labs Limited Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lyka Labs Limited Main Business Overview
13.7.5 Lyka Labs Limited Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Tigecycline Product Offered
13.8.3 Fresenius Kabi Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Sandoz
13.9.1 Sandoz Company Information
13.9.2 Sandoz Tigecycline Product Offered
13.9.3 Sandoz Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sandoz Main Business Overview
13.9.5 Sandoz Latest Developments
13.10 APOTEX
13.10.1 APOTEX Company Information
13.10.2 APOTEX Tigecycline Product Offered
13.10.3 APOTEX Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 APOTEX Main Business Overview
13.10.5 APOTEX Latest Developments
13.11 Accord Healthcare
13.11.1 Accord Healthcare Company Information
13.11.2 Accord Healthcare Tigecycline Product Offered
13.11.3 Accord Healthcare Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Accord Healthcare Main Business Overview
13.11.5 Accord Healthcare Latest Developments
13.12 Amneal Pharmaceuticals
13.12.1 Amneal Pharmaceuticals Company Information
13.12.2 Amneal Pharmaceuticals Tigecycline Product Offered
13.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Amneal Pharmaceuticals Main Business Overview
13.12.5 Amneal Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tigecycline Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tigecycline by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tigecycline by Country/Region, 2019, 2023 & 2030
2.2 Tigecycline Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Tigecycline Sales by Type
2.3.1 Global Tigecycline Sales Market Share by Type (2019-2022)
2.3.2 Global Tigecycline Revenue and Market Share by Type (2019-2022)
2.3.3 Global Tigecycline Sale Price by Type (2019-2022)
2.4 Tigecycline Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.5 Tigecycline Sales by Application
2.5.1 Global Tigecycline Sale Market Share by Application (2019-2022)
2.5.2 Global Tigecycline Revenue and Market Share by Application (2019-2022)
2.5.3 Global Tigecycline Sale Price by Application (2019-2022)
3 Global Tigecycline by Company
3.1 Global Tigecycline Breakdown Data by Company
3.1.1 Global Tigecycline Annual Sales by Company (2020-2022)
3.1.2 Global Tigecycline Sales Market Share by Company (2020-2022)
3.2 Global Tigecycline Annual Revenue by Company (2020-2022)
3.2.1 Global Tigecycline Revenue by Company (2020-2022)
3.2.2 Global Tigecycline Revenue Market Share by Company (2020-2022)
3.3 Global Tigecycline Sale Price by Company
3.4 Key Manufacturers Tigecycline Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tigecycline Product Location Distribution
3.4.2 Players Tigecycline Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tigecycline by Geographic Region
4.1 World Historic Tigecycline Market Size by Geographic Region (2019-2022)
4.1.1 Global Tigecycline Annual Sales by Geographic Region (2019-2022)
4.1.2 Global Tigecycline Annual Revenue by Geographic Region
4.2 World Historic Tigecycline Market Size by Country/Region (2019-2022)
4.2.1 Global Tigecycline Annual Sales by Country/Region (2019-2022)
4.2.2 Global Tigecycline Annual Revenue by Country/Region
4.3 Americas Tigecycline Sales Growth
4.4 APAC Tigecycline Sales Growth
4.5 Europe Tigecycline Sales Growth
4.6 Middle East & Africa Tigecycline Sales Growth
5 Americas
5.1 Americas Tigecycline Sales by Country
5.1.1 Americas Tigecycline Sales by Country (2019-2022)
5.1.2 Americas Tigecycline Revenue by Country (2019-2022)
5.2 Americas Tigecycline Sales by Type
5.3 Americas Tigecycline Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tigecycline Sales by Region
6.1.1 APAC Tigecycline Sales by Region (2019-2022)
6.1.2 APAC Tigecycline Revenue by Region (2019-2022)
6.2 APAC Tigecycline Sales by Type
6.3 APAC Tigecycline Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tigecycline by Country
7.1.1 Europe Tigecycline Sales by Country (2019-2022)
7.1.2 Europe Tigecycline Revenue by Country (2019-2022)
7.2 Europe Tigecycline Sales by Type
7.3 Europe Tigecycline Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tigecycline by Country
8.1.1 Middle East & Africa Tigecycline Sales by Country (2019-2022)
8.1.2 Middle East & Africa Tigecycline Revenue by Country (2019-2022)
8.2 Middle East & Africa Tigecycline Sales by Type
8.3 Middle East & Africa Tigecycline Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tigecycline
10.3 Manufacturing Process Analysis of Tigecycline
10.4 Industry Chain Structure of Tigecycline
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tigecycline Distributors
11.3 Tigecycline Customer
12 World Forecast Review for Tigecycline by Geographic Region
12.1 Global Tigecycline Market Size Forecast by Region
12.1.1 Global Tigecycline Forecast by Region (2023-2030)
12.1.2 Global Tigecycline Annual Revenue Forecast by Region (2023-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tigecycline Forecast by Type
12.7 Global Tigecycline Forecast by Application
13 Key Players Analysis
13.1 Pfizer (Wyeth)
13.1.1 Pfizer (Wyeth) Company Information
13.1.2 Pfizer (Wyeth) Tigecycline Product Offered
13.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer (Wyeth) Main Business Overview
13.1.5 Pfizer (Wyeth) Latest Developments
13.2 Sino Biopharmaceutical
13.2.1 Sino Biopharmaceutical Company Information
13.2.2 Sino Biopharmaceutical Tigecycline Product Offered
13.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sino Biopharmaceutical Main Business Overview
13.2.5 Sino Biopharmaceutical Latest Developments
13.3 Zhejiang Hisun Pharma
13.3.1 Zhejiang Hisun Pharma Company Information
13.3.2 Zhejiang Hisun Pharma Tigecycline Product Offered
13.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zhejiang Hisun Pharma Main Business Overview
13.3.5 Zhejiang Hisun Pharma Latest Developments
13.4 Jiangsu Hansoh Pharmaceutical
13.4.1 Jiangsu Hansoh Pharmaceutical Company Information
13.4.2 Jiangsu Hansoh Pharmaceutical Tigecycline Product Offered
13.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.4.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Tigecycline Product Offered
13.5.3 Abbott Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Natco Pharma
13.6.1 Natco Pharma Company Information
13.6.2 Natco Pharma Tigecycline Product Offered
13.6.3 Natco Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Natco Pharma Main Business Overview
13.6.5 Natco Pharma Latest Developments
13.7 Lyka Labs Limited
13.7.1 Lyka Labs Limited Company Information
13.7.2 Lyka Labs Limited Tigecycline Product Offered
13.7.3 Lyka Labs Limited Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lyka Labs Limited Main Business Overview
13.7.5 Lyka Labs Limited Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Tigecycline Product Offered
13.8.3 Fresenius Kabi Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Sandoz
13.9.1 Sandoz Company Information
13.9.2 Sandoz Tigecycline Product Offered
13.9.3 Sandoz Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sandoz Main Business Overview
13.9.5 Sandoz Latest Developments
13.10 APOTEX
13.10.1 APOTEX Company Information
13.10.2 APOTEX Tigecycline Product Offered
13.10.3 APOTEX Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 APOTEX Main Business Overview
13.10.5 APOTEX Latest Developments
13.11 Accord Healthcare
13.11.1 Accord Healthcare Company Information
13.11.2 Accord Healthcare Tigecycline Product Offered
13.11.3 Accord Healthcare Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Accord Healthcare Main Business Overview
13.11.5 Accord Healthcare Latest Developments
13.12 Amneal Pharmaceuticals
13.12.1 Amneal Pharmaceuticals Company Information
13.12.2 Amneal Pharmaceuticals Tigecycline Product Offered
13.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Amneal Pharmaceuticals Main Business Overview
13.12.5 Amneal Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
no record found